A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.
- DOI
- 10.1016/j.lungcan.2025.108870
- Published
- 2026 Jan
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2025.108870,
title = {A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.},
author = {Zhang B and Alder L and Rosner S and Desai A and Cooper AJ and Yimer H and Bogdanska W and Naqash AR and Taylor A and Joshi U and Carlisle J and Champiat S and Altan M and Vega MF and Halm J and Manzano JG and Fenton G and Nie Y and Wang K and Parma M and Rudin CM and Chiang A and Byers LA and Gay CM and Puri S},
year = {2026},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2025.108870},
url = {https://doi.org/10.1016/j.lungcan.2025.108870}
}RIS
TY - JOUR TI - A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS. AU - Zhang B AU - Alder L AU - Rosner S AU - Desai A AU - Cooper AJ AU - Yimer H AU - Bogdanska W AU - Naqash AR AU - Taylor A AU - Joshi U AU - Carlisle J AU - Champiat S AU - Altan M AU - Vega MF AU - Halm J AU - Manzano JG AU - Fenton G AU - Nie Y AU - Wang K AU - Parma M AU - Rudin CM AU - Chiang A AU - Byers LA AU - Gay CM AU - Puri S PY - 2026 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2025.108870 UR - https://doi.org/10.1016/j.lungcan.2025.108870 ER -
APA
B, Z., L, A., S, R., A, D., AJ, C., H, Y., W, B., AR, N., A, T., U, J., J, C., S, C., M, A., MF, V., J, H., JG, M., G, F., Y, N., K, W., M, P., CM, R., A, C., LA, B., CM, G., & S, P. (2026). A multi-institutional perspective on tarlatamab administration and management of CRS/ICANS.. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2025.108870
Source records
- pubmed · retrieved 2026-09-27T13:18:27.061Z
- europe-pmc · retrieved 2026-09-27T13:18:27.071Z